The Essentials of Multiomics

Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificia...

ver descrição completa

Detalhes bibliográficos
Autores: Marshall, John L, Peshkin, Beth N., Yoshino, Takayuki, Vowinckel, Jakob, Danielsen, Håvard E, Melino, Gerry, Tsamardinos, Ioannis, Haudenschild, Christian, Kerr, David J, Sampaio, Carlos, Young Rha, Sun, Fitz Gerald, Kevin T, Holland, Eric C, Gallagher, David, García-Foncillas López, Jesús Miguel, Juhl, Hartmut
Tipo de documento: artigo
Data de publicação:2022
País:España
Recursos:Universidad Autónoma de Madrid
Repositório:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglês
OAI Identifier:oai:repositorio.uam.es:10486/712104
Acesso em linha:http://hdl.handle.net/10486/712104
https://dx.doi.org/10.1093/oncolo/oyab048
Access Level:Acceso aberto
Palavra-chave:cancer
multiomics
genomics
transcriptomics
proteomics
digital pathology
machine learning
artificial intelligence
Medicina
Descrição
Resumo:Within the last decade, the science of molecular testing has evolved from single gene and single protein analysis to broad molecular profiling as a standard of care, quickly transitioning from research to practice. Terms such as genomics, transcriptomics, proteomics, circulating omics, and artificial intelligence are now commonplace, and this rapid evolution has left us with a significant knowledge gap within the medical community. In this paper, we attempt to bridge that gap and prepare the physician in oncology for multiomics, a group of technologies that have gone from looming on the horizon to become a clinical reality. The era of multiomics is here, and we must prepare ourselves for this exciting new age of cancer medicine